Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.

Woods D, Hayashi RJ, Binkley MM, Sparks GW, Hulbert ML.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26635. Epub 2017 May 19.

PMID:
28544309
2.

A pilot study of manual chronic partial exchange transfusion in children with sickle disease.

Aloni MN, LĂȘ PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A.

Hematology. 2015 Jun;20(5):284-8. doi: 10.1179/1607845414Y.0000000191. Epub 2014 Aug 18.

PMID:
25133935
3.

Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.

Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER.

Transfusion. 2016 Jul;56(7):1707-15. doi: 10.1111/trf.13558. Epub 2016 Mar 20.

PMID:
26997031
4.

Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.

Koehl B, Sommet J, Holvoet L, Abdoul H, Boizeau P, Ithier G, Missud F, Couque N, Verlhac S, Voultoury P, Sellami F, Baruchel A, Benkerrou M.

Transfusion. 2016 May;56(5):1121-8. doi: 10.1111/trf.13548. Epub 2016 Mar 28.

PMID:
27021622
5.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146. doi: 10.1002/14651858.CD003146.pub3. Review.

PMID:
28094851
6.

Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.

Kim HC, Dugan NP, Silber JH, Martin MB, Schwartz E, Ohene-Frempong K, Cohen AR.

Blood. 1994 Feb 15;83(4):1136-42.

7.

Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.

Savage WJ, Reddoch S, Wolfe J, Casella JF.

J Pediatr Hematol Oncol. 2013 Aug;35(6):434-6. doi: 10.1097/MPH.0b013e31829d470d.

8.

Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.

Hilliard LM, Williams BF, Lounsbury AE, Howard TH.

Am J Hematol. 1998 Sep;59(1):28-35.

9.

Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.

Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E.

Transfusion. 2012 Dec;52(12):2671-6. doi: 10.1111/j.1537-2995.2012.03659.x. Epub 2012 Apr 23.

PMID:
22519830
10.

Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.

Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.

J Pediatr Hematol Oncol. 2009 May;31(5):309-12. doi: 10.1097/MPH.0b013e3181a1c143.

PMID:
19415007
11.

[Iron overload in sickle cell anemia : a study of 94 patients].

Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.

Tunis Med. 2011 Jun;89(6):548-52. French.

12.

Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.

Mian HS, Ward R, Telfer P, Kaya B, Kuo KH.

Hemoglobin. 2015;39(5):310-5. doi: 10.3109/03630269.2015.1057734. Epub 2015 Jun 26.

PMID:
26114740
13.

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E.

Blood. 2000 Jul 1;96(1):76-9.

14.

Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.

Stanley HM, Friedman DF, Webb J, Kwiatkowski JL.

Pediatr Blood Cancer. 2016 Aug;63(8):1414-8. doi: 10.1002/pbc.26017. Epub 2016 Apr 21.

15.

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.

Ware RE, Schultz WH, Yovetich N, Mortier NA, Alvarez O, Hilliard L, Iyer RV, Miller ST, Rogers ZR, Scott JP, Waclawiw M, Helms RW.

Pediatr Blood Cancer. 2011 Dec 1;57(6):1011-7. doi: 10.1002/pbc.23145. Epub 2011 Aug 8.

16.
17.

Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.

Pack-Mabien A, Brown B, Herbert DE, Haynes J Jr.

J Am Assoc Nurse Pract. 2015 Oct;27(10):591-6. doi: 10.1002/2327-6924.12221. Epub 2015 Feb 25.

PMID:
25711464
18.

Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M.

Eur J Haematol. 2010 Mar;84(3):259-65. doi: 10.1111/j.1600-0609.2009.01379.x. Epub 2009 Nov 12.

PMID:
19912310
19.

Hemoglobin Variants Acquired Post-Exchange Transfusion in Pediatric Sickle Cell Disease (SCD) Patients.

Pandey S, Cottler-Fox M, Drobena G.

Ann Clin Lab Sci. 2015 Fall;45(6):627-30.

PMID:
26663791
20.

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

Adams DM, Schultz WH, Ware RE, Kinney TR.

J Pediatr Hematol Oncol. 1996 Feb;18(1):46-50.

PMID:
8556370

Supplemental Content

Support Center